Ritschel, Franziska
Geisler, Daniel
King, Joseph A.
Bernardoni, Fabio
Seidel, Maria
Boehm, Ilka
Vettermann, Richard
Biemann, Ronald
Roessner, Veit
Smolka, Michael N. http://orcid.org/0000-0001-5398-5569
Ehrlich, Stefan
Article History
Received: 5 January 2017
Accepted: 19 May 2017
First Online: 14 July 2017
Competing Interests
: In the last two years, Dr. Roessner has received payment for consulting and writing activities from Lilly, Novartis, and Shire Pharmaceuticals, lecture honoraria from Lilly, Novartis, Shire Pharmaceuticals, and Medice Pharma, and support for research from Shire and Novartis. He has carried out (and is currently carrying out) clinical trials in cooperation with the Novartis, Shire, and Otsuka companies.